Translate:
Sign Up
TwitterFacebookLinkedin
Search
  • Dr. Brian Koffman’s Blog
More Links
CLL SocietyCLL Society
CLL Society
Patients and providers fighting CLL together
Smart Patients Get Smart Care™
Donate to CLL Society
  • Home
  • Basics
    • Basic Terms
    • Getting Started
    • Test Before Treat™
    • Early Care
    • Treatment
    • Cake of Cure for CLL
    • CLL Comic Book
    • CLL FAQs
  • Beyond The Basics
    • CLL Overview by Dr. Kipps
    • Richter’s Transformation
    • CAR-T and Other Cellular Therapies
    • Treatment
    • What About CT Scans?
    • How is Treatment Selected?
    • Advanced Prognostics
  • Living Well With CLL
    • Paid Market Research Opportunities
    • Impact of Diagnosis
    • Taking Charge
    • Becoming Informed
    • Support
    • Caregivers
    • Planning Ahead
  • Clinical Trials
    • The Basics
    • The Patient Perspective
    • News about Clinical Trials
  • Conference Coverage
    • 2019 Conferences
    • 2018 Conferences
    • Past Years
      • 2017 Conferences
      • 2016 Conferences
      • 2015 Conferences
      • 2014 Conferences
      • 2013 Conferences
    • Links To Blog Conference Coverage
  • CAR-T
  • Support Groups/Education
    • CLL Society Patient & Caregiver Educational Forums
    • The CLL Bloodline
    • Support Group Calendar
    • Support Group Contact
    • Leader Resources
    • CLL-Specific Patient Support Groups
    • Upcoming CLL Patient Education Programs
    • Archived Educational Activities
  • News
    • CLL Society in the News
    • The CLL Society Tribune
      • Ask & Tell
      • Ask The Doctor
      • Ask The Pharmacist
      • Did You Know?
    • Business, Finances, Insurance & Regulatory
    • Official Statements and Press Releases
    • Publications and Research
    • Clinical
    • CLL Society Alerts
  • About Us
    • Contact
    • Mission & Vision
    • Board of Directors
    • Medical Advisory Board
    • Patient Advisory Board
    • The CLL Society Staff
    • The Orange County CLL Support Group
    • Volunteer With Us!
Menu back  

Category Archives: News

You are here:
  1. Home
  2. Category "News"

New Test Approved for Payment by Medicare for Measuring Minimal Residual Disease (MRD) in Chronic Lymphocytic Leukemia or CLL

Looking with greater and greater accuracy for persistent cancer cells can help better inform when to stop and maybe when...
January 12, 2020Business, Finances, Insurance & RegulatoryBy Brad Hedrick

Hidden Forces Interview with Dr. Brian Koffman

In the Dec 23, 2019 episode of Hidden Forces, “Demetri Kofinas speaks with Brian Koffman, a doctor turned CLL patient,...
December 26, 2019CLL Society NewsBy Brad Hedrick

CLL Society to Present Innovative Telemedicine Platform Study at American Society of Hematology Annual Conference

CLL Society to Present Innovative Telemedicine Platform Study at American Society of Hematology Annual Conference CLL Society co-founder and Medical Director...
December 1, 2019Official Statements and Press ReleasesBy Brad Hedrick

U.S. Food and Drug Administration (FDA) Approves Acalabrutinib for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

For immediate release, Nov 21. 2019 U.S. Food and Drug Administration (FDA) Approves Acalabrutinib for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) On...
November 21, 2019Official Statements and Press ReleasesBy Brad Hedrick

The FDA announced Breakthrough Therapy Designation (BTD) for acalabrutinib (Calquence) as a single agent to treat chronic lymphocytic leukemia (CLL)

Acalabrutinib is already approved to treat mantle cell lymphoma, but with BTD for CLL, that means it is one step...
August 15, 2019Business, Finances, Insurance & RegulatoryBy Brad Hedrick

Ibrutinib and Rituximab (IR) is Superior to Chemo-immunotherapy (CIT) in CLL: Big News, or is it really? And did they get it right?

When CNN has a headline that Chemo-free drug combo shows 'dramatic' improvement against common leukemia in adults and reports on...
August 6, 2019ClinicalBy Brad Hedrick

Shuttering of the Biden Cancer Initiative

The cancer moonshot lead by VP Joe Biden started with such promise, but it is on hold now due to...
August 5, 2019Business, Finances, Insurance & RegulatoryBy Brad Hedrick

Approval of a biosimilar for Rituximab

The approval of Ruxience (rituximab-pvvr) (Pfizer) a biosimilar for the originator product Rituxan (Genentech) brings the total number of FDA...
July 29, 2019Business, Finances, Insurance & RegulatoryBy Brad Hedrick

AbbVie reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for VENCLEXTA®, a treatment for chronic lymphocytic leukemia (CLL)

"MONTREAL , May 23, 2019 /CNW/ - AbbVie (ABBV), a global, research and development-driven biopharmaceutical company, announced today that Ontario...
May 29, 2019Business, Finances, Insurance & RegulatoryBy Brad Hedrick

May 15, 2019: FDA approved venetoclax in combination with obinutuzumab for the treatment of people with previously untreated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL)

This is very big news. This is the first non-chemotherapy based fixed duration treatment for CLL in treatment naïve patients. Until this...
May 20, 2019Business, Finances, Insurance & RegulatoryBy Brad Hedrick
12345…
67891011
12
Next page
  • Home
  • Basics
    • Basic Terms
    • Getting Started
    • Test Before Treat™
    • Early Care
    • Treatment
    • Cake of Cure for CLL
    • CLL Comic Book
    • CLL FAQs
  • Beyond The Basics
    • CLL Overview by Dr. Kipps
    • Richter’s Transformation
    • CAR-T and Other Cellular Therapies
    • Treatment
    • What About CT Scans?
    • How is Treatment Selected?
    • Advanced Prognostics
  • Living Well With CLL
    • Paid Market Research Opportunities
    • Impact of Diagnosis
    • Taking Charge
    • Becoming Informed
    • Support
    • Caregivers
    • Planning Ahead
  • Clinical Trials
    • The Basics
    • The Patient Perspective
    • News about Clinical Trials
  • Conference Coverage
    • 2019 Conferences
    • 2018 Conferences
    • Past Years
      • 2017 Conferences
      • 2016 Conferences
      • 2015 Conferences
      • 2014 Conferences
      • 2013 Conferences
    • Links To Blog Conference Coverage
  • CAR-T
  • Support Groups/Education
    • CLL Society Patient & Caregiver Educational Forums
    • The CLL Bloodline
    • Support Group Calendar
    • Support Group Contact
    • Leader Resources
    • CLL-Specific Patient Support Groups
    • Upcoming CLL Patient Education Programs
    • Archived Educational Activities
  • News
    • CLL Society in the News
    • The CLL Society Tribune
      • Ask & Tell
      • Ask The Doctor
      • Ask The Pharmacist
      • Did You Know?
    • Business, Finances, Insurance & Regulatory
    • Official Statements and Press Releases
    • Publications and Research
    • Clinical
    • CLL Society Alerts
  • About Us
    • Contact
    • Mission & Vision
    • Board of Directors
    • Medical Advisory Board
    • Patient Advisory Board
    • The CLL Society Staff
    • The Orange County CLL Support Group
    • Volunteer With Us!
Navigation
We’d like to thank our supporters:
  • AbbVie
  • AstraZeneca
  • Beigene
  • Celgene
  • Genentech/Biogen Idec
  • Gilead
  • Juno
  • Pharmacyclics/Janssen
  • Sunesis Pharmaceuticals
  • TG Therapeutics
  • Verastem
Copyright 2019 CLL Society, Inc. All Rights Reserved.
Terms & Conditions | Privacy Policy





Social media & sharing icons powered by UltimatelySocial
This site uses cookies: Find out more.